China National Medicines Corporation Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 49,592.05 million compared to CNY 45,435.63 million a year ago. Revenue was CNY 49,696.05 million compared to CNY 45,498.58 million a year ago.

Net income was CNY 2,146 million compared to CNY 1,964.06 million a year ago. Basic earnings per share from continuing operations was CNY 2.8443 compared to CNY 2.6031 a year ago. Diluted earnings per share from continuing operations was CNY 2.8443 compared to CNY 2.6031 a year ago.